Hip joint disorder requiring total hip replacement surgery Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients over 20 years of age 2. Preoperative diagnosis of osteoarthritis, avascular necrosis, or rheumatoid arthritis 3. Consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Previous operation (total hip arthroplasty, osteotomy, tenotomy around hip joint) 2. Bilateral hip disorder 3. Rheumatoid arthritis of Charnley category C (multiple joint disease or other disease limiting mobility) 4. Past history of deep venous thrombosis or pulmonary embolism, metal allergy, severe obesity (Body Mass Index >35.0 kg/m²) 5. Severe diabetes mellitus 6. Infection around the hip joint
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical outcomes assessed using the Japanese Orthopaedic Association (JOA) hip scores before the surgery, 6 weeks, 3 months, 6 months, and 1 year postoperatively 2. Pain, activities of daily life and mental health status assessed using the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JHEQ) before the surgery, 3 months, 6 months, and 1 year postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| The inhibition of stress shielding by the TNS stem assessed using radiographic images at 12 months | — |
Countries
Japan